Next Generation Sequencing Market by Technology (Targeted Sequencing & Re-Sequencing, Whole Exome Sequencing, Whole Genome Sequencing), Product Type (Consumables, Platforms, Services), Application, End User - Global Forecast 2024-2030

Next Generation Sequencing Market by Technology (Targeted Sequencing & Re-Sequencing, Whole Exome Sequencing, Whole Genome Sequencing), Product Type (Consumables, Platforms, Services), Application, End User - Global Forecast 2024-2030

The Next Generation Sequencing Market size was estimated at USD 17.73 billion in 2023 and expected to reach USD 21.38 billion in 2024, at a CAGR 23.61% to reach USD 78.21 billion by 2030.Next-generation sequencing (NGS) is the parallel sequencing technology that delivers ultra-high throughput, scalability, and speed. The technology is operated to determine the order of nucleotides in whole genomes or targeted regions of DNA or RNA. This high-throughput technique defines a part of the nucleotide sequence of an individual's genome that utilizes DNA sequencing technologies capable of processing multiple DNA sequences in parallel. Governments worldwide strive to keep healthcare expenditure affordable while providing equal access to high-quality care, leading to increased awareness and adoption of clinical diagnostics among patients, such as NGS technology. Growing technological developments in NGS instruments and technologies and rising adoption by the agriculture sector are driving the market growth. However, privacy concerns regarding next-generation sequencing data protection and a need for computation resources for next-generation sequencing hamper market growth. Continuous technological development of NGS products and government support and initiatives are expected to create significant market opportunities in the future.

Regional Insights

The Americas is a significant market in next-generation sequencing owing to the increasing number of research projects, rising demand for new NGS platforms, and growing use of NGS consumables projected market development. With high R&D investment and the availability of a technologically developed healthcare research framework, the development of whole genome sequencing (WGS) in the region is a critical factor for the market's growth. In Europe, increasing usage of NGS in the centers performing ground-level research and rising development and advancement in research in sequencing have created a significant expansion in the region. In the Asia-Pacific, the market is estimated to grow rapidly over the forecast period owing to the presence of substantial developments by China and Japan for technological integration of NGS methodologies and the development of healthcare, R&D, and clinical development frameworks of emerging economies such as India and Australia have poised the Asia-Pacific NGS market to witness lucrative opportunities of expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Next Generation Sequencing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next Generation Sequencing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Next Generation Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., ATDBio Ltd., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., BIO3 SCIENTIFIC SDN BHD, bioMerieux S.A., BioVendor–Laboratorní medicína a.s, Cambridge Bioscience Limited, CD Genomics, CeGaT GmbH, Charles River Laboratories, Inc., DNAnexus, Inc., DNASTAR, Inc., ELEMENT BIOSCIENCES, Enzo Life Sciences, Inc., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fraunhofer-Gesellschaft, GENEWIZ, Genomatix, GenPath, GenScript Biotech Corporation, GRAIL, LLC, Hamilton Company, Illumina, Inc., Integrated DNA Technologies, Inc., Invivoscribe, Inc., iRepertoire, Inc., LabMal, Macrogen, Inc., Medigene Sdn Bhd., Merck KGaA, NanoString Technologies, Inc., Neoscience, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PathoQuest, PCR Biosystems Ltd., Perkin Elmer, Inc., Promega Corporation, PT Pandu Biosains, Qiagen N.V., Resolution Bioscience, Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Next Generation Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology

Targeted Sequencing & Re-Sequencing

Whole Exome Sequencing

Whole Genome Sequencing
Product Type

Consumables

Platforms

Services
Application

Agriculture

Animal science & Veterinary Research

Diagnostics

Drug Discovery
End User

Academic & Research Institutes

Clinical Laboratories

Contract Research Organization

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Next Generation Sequencing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next Generation Sequencing Market?
3. What are the technology trends and regulatory frameworks in the Next Generation Sequencing Market?
4. What is the market share of the leading vendors in the Next Generation Sequencing Market?
5. Which modes and strategic moves are suitable for entering the Next Generation Sequencing Market?

Note: PDF & Excel + Online Access - 1 Year Show more